1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX

Neurocrine Biosciences, Inc. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Read More
140.90 0.46 (0.33%)
67.28% Gain from 52W Low
780.5K
XNAS Volume

XNAS 16 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Neurocrine Biosciences, Inc. is scheduled for today, for the purpose of TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry and Epilepsy Virtual Summit See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
33.7 / 100
Momentum Score
Technically Neutral
59.6 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
168
1Yr Price target upside is 19%
26 analysts

24

S

8

W

2

O

1

T

SWOT Analysis

Neurocrine Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..